IGF-1 cancer growth pathway diagram showing IGF-1 receptor activating PI3K AKT, MAPK ERK, and mTOR signaling involved in tumor growth.

IGF-1 and Cancer: Understanding the Insulin-Like Growth Factor Pathway

What Is IGF-1?

IGF-1 stands for Insulin-Like Growth Factor-1. It is a hormone that plays a major role in growth, cell repair, and metabolism.

The body produces IGF-1 mainly in the liver after stimulation from growth hormone (GH) released by the pituitary gland. Once released into the bloodstream, IGF-1 travels through the body and signals cells to grow, divide, and survive.

In healthy conditions, this system helps with:

  • Childhood growth
  • Tissue repair
  • Muscle development
  • Bone density
  • Metabolic regulation

However, because IGF-1 strongly stimulates cell growth and survival, scientists have long studied its role in cancer development and tumor growth.

Many cancers use the IGF-1 signaling system to support their growth and resist cell death.


The IGF-1 Signaling Pathway

IGF-1 works by binding to a protein on cell surfaces called the IGF-1 receptor (IGF-1R).

When IGF-1 attaches to this receptor, it activates a series of signals inside the cell. These signals tell the cell to:

  • Grow
  • Divide
  • Avoid programmed cell death
  • Produce energy
  • Repair damage

Several important cancer-related pathways are activated by IGF-1 signaling, including:

  • PI3K / AKT pathway
  • MAPK / ERK pathway
  • mTOR signaling

These pathways are known to regulate cell growth, metabolism, and survival. When they become overactive, cells may divide uncontrollably, which is a hallmark of cancer.

Because of this, the IGF-1 pathway is often considered a growth accelerator for tumors.


How IGF-1 May Contribute to Cancer

Researchers have identified several ways IGF-1 can support cancer development.

1. Stimulating Cell Proliferation

One of the most important functions of IGF-1 is stimulating cell division.

Cancer cells take advantage of this signal. By activating IGF-1 receptors, tumor cells can increase their rate of replication.

Studies show IGF signaling promotes tumor cell proliferation, migration, and invasion, which can lead to cancer progression and spread.


2. Blocking Apoptosis (Cell Death)

Healthy cells have built-in safety mechanisms that trigger apoptosis, a process where damaged cells self-destruct.

Cancer cells often disable these safety systems.

IGF-1 signaling helps cells avoid apoptosis, allowing abnormal cells to survive longer than they should.

This survival signal allows cancer cells to accumulate mutations and continue growing.


3. Supporting Tumor Growth

Tumors require constant growth signals to expand.

IGF-1 acts as a powerful growth factor, encouraging cells to multiply and supporting tumor expansion.

Research shows abnormal IGF signaling is linked to several cancers, including:

  • Colon cancer
  • Prostate cancer
  • Breast cancer
  • Pancreatic cancer
  • Melanoma

Because of this, IGF-1 signaling is considered one of the key growth drivers in oncology research.


4. Promoting Angiogenesis

Tumors need a blood supply to survive.

IGF-1 can stimulate angiogenesis, the formation of new blood vessels that feed tumors with oxygen and nutrients.

This allows tumors to grow larger and become more aggressive.


5. Helping Cancer Spread (Metastasis)

Cancer becomes more dangerous when it spreads to other organs.

IGF-1 signaling can increase the ability of cancer cells to:

  • Move
  • Invade nearby tissues
  • Travel through blood vessels

These processes are essential for metastasis, which is responsible for most cancer deaths.


IGF-1 and Cancer Risk

Scientists have also studied whether higher IGF-1 levels increase cancer risk.

Large population studies have found that people with higher blood levels of IGF-1 may have an increased risk of certain cancers.

Research suggests associations between elevated IGF-1 levels and cancers such as:

  • Breast cancer
  • Prostate cancer
  • Colorectal cancer
  • Lung cancer

One large study also found higher IGF-1 levels were linked with increased risk of breast and prostate cancers.

However, scientists emphasize that this relationship is complex.

High IGF-1 does not necessarily cause cancer directly. Instead, it may create conditions that make tumor growth easier if cancer cells are already present.


IGF-1 and the Tumor Microenvironment

Cancer does not grow in isolation.

Tumors exist within a complex environment of immune cells, blood vessels, and signaling molecules.

IGF-1 can influence this environment by:

  • Changing immune responses
  • Supporting tumor survival
  • Increasing resistance to therapy

Studies suggest IGF-1 signaling may help tumors escape immune detection, making them harder for the immune system to eliminate.

This is one reason researchers are investigating IGF-1 as a target for cancer treatment.


IGF-1 and Treatment Resistance

Another important role of the IGF pathway is its contribution to therapy resistance.

Cancer treatments such as chemotherapy and radiation aim to damage tumor cells and trigger cell death.

However, IGF-1 signaling can activate survival pathways that help cancer cells recover from treatment damage.

Researchers have found that the IGF pathway may contribute to:

  • Chemotherapy resistance
  • Hormone therapy resistance
  • Radiation resistance

Because of this, blocking IGF-1 signaling is an area of active drug development.


Targeting IGF-1 in Cancer Therapy

Scientists have developed several strategies to block the IGF-1 pathway.

These include:

IGF-1 Receptor Inhibitors

Drugs designed to block the IGF-1 receptor (IGF-1R) prevent growth signals from reaching cancer cells.

Monoclonal Antibodies

These antibodies attach to IGF-1 receptors and stop the hormone from activating tumor growth signals.

Combination Therapies

Researchers are also studying treatments that combine:

  • IGF-1 pathway inhibitors
  • Chemotherapy
  • Targeted cancer drugs
  • Immunotherapy

The goal is to weaken cancer cells’ survival signals and make treatments more effective.


IGF-1 and Lifestyle Factors

Several lifestyle factors influence IGF-1 levels in the body.

These include:

Diet

High protein intake and high calorie consumption may increase IGF-1 levels.

Obesity

Obesity is linked to increased activity of insulin and IGF signaling, which may contribute to cancer development.

Physical Activity

Exercise can influence hormone balance and metabolic pathways connected to IGF-1.

Age

IGF-1 levels naturally peak during adolescence and decline with age.

Understanding how these factors influence IGF-1 is an active area of research in cancer prevention.


Why IGF-1 Matters in Cancer Research

The IGF-1 system sits at the intersection of several major biological systems:

  • Growth hormone signaling
  • Insulin metabolism
  • Nutrient sensing
  • Cellular growth pathways

Because of this central role, IGF-1 interacts with many of the pathways known to drive cancer, including:

  • mTOR
  • PI3K / AKT
  • RAS / MAPK

These pathways regulate cell survival, metabolism, and growth, making them major targets for modern cancer research.

Scientists believe that understanding the IGF-1 system could lead to:

  • Better cancer prevention strategies
  • More precise targeted therapies
  • Improved understanding of tumor biology

Key Takeaways

IGF-1 is a powerful growth hormone that helps regulate cell growth, repair, and metabolism.

While essential for normal health, abnormal IGF-1 signaling may contribute to cancer by:

  • Stimulating tumor growth
  • Preventing cancer cell death
  • Supporting metastasis
  • Increasing treatment resistance

Higher circulating IGF-1 levels have been associated with increased risk for several cancers, although the relationship is complex and influenced by many factors.

Because of its central role in cell growth and survival, the IGF-1 pathway remains an important focus in modern cancer research and drug development.

References

  1. National Cancer Institute – Cancer Biology
    https://www.cancer.gov/
  2. Insulin-like growth factors in cancer biology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383470/
  3. IGF-1 receptor signaling in cancer
    https://www.nature.com/articles/nrc.2017.109
  4. IGF-1 levels and cancer risk study
    https://www.sciencedirect.com/science/article/abs/pii/S1470204502007313
  5. American Cancer Society – How Cancer Grows
    https://www.cancer.org/
IGF-1 cancer growth pathway diagram showing IGF-1 receptor activating PI3K AKT, MAPK ERK, and mTOR signaling involved in tumor growth.
Illustration of how the IGF-1 growth factor activates signaling pathways such as PI3K/AKT, MAPK/ERK, and mTOR that can support tumor growth and survival.